AA
AVXL icon

ALPS Advisors’s Anavex Life Sciences AVXL Stock Holding History

ALPS Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Buy
94,051
+18,608
+25% +$55.1K ﹤0.01% 1138
2026
Q1 		$232K Buy
75,443
+2,082
+3% +$9.02K ﹤0.01% 987
2025
Q4 		$261K Buy
73,361
+34,755
+90% +$213K ﹤0.01% 952
2025
Q3 		$344K Sell
38,606
-7,474
-16% -$75.8K ﹤0.01% 942
2025
Q2 		$425K Sell
46,080
-14,140
-23% -$121K ﹤0.01% 726
2025
Q1 		$517K Sell
60,220
-8,346
-12% -$78.8K ﹤0.01% 587
2024
Q4 		$736K Buy
68,566
+4,587
+7% +$35.3K ﹤0.01% 545
2024
Q3 		$363K Sell
63,979
-2,070
-3% -$11.9K ﹤0.01% 791
2024
Q2 		$279K Buy
66,049
+8,136
+14% +$32.9K ﹤0.01% 871
2024
Q1 		$295K Buy
57,913
+1,782
+3% +$10K ﹤0.01% 905
2023
Q4 		$523K Sell
56,131
-4,320
-7% -$29.7K ﹤0.01% 600
2023
Q3 		$396K Buy
60,451
+1,031
+2% +$8.21K ﹤0.01% 626
2023
Q2 		$483K Buy
59,420
+8,007
+16% +$68.6K ﹤0.01% 618
2023
Q1 		$441K Sell
51,413
-1,511
-3% -$15.1K ﹤0.01% 603
2022
Q4 		$490K Buy
52,924
+10,424
+25% +$111K ﹤0.01% 595
2022
Q3 		$439K Sell
42,500
-3,426
-7% -$36.2K ﹤0.01% 631
2022
Q2 		$460K Sell
45,926
-32,360
-41% -$307K ﹤0.01% 624
2022
Q1 		$964K Sell
78,286
-9,686
-11% -$119K 0.01% 316
2021
Q4 		$1.52M Buy
+87,972
New +$1.67M 0.02% 317

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ALPS Advisors's AVXL Position: Q2 2026 in Review

ALPS Advisors increased its Anavex Life Sciences (AVXL) stake by 25% in Q2 2026, buying an estimated $55.1K and bringing the position to 94,051 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #1138.

ALPS Advisors first reported a position in AVXL in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.52M in Q4 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • ALPS Advisors held 94,051 shares of Anavex Life Sciences worth $244K as of Q2 2026.
  • ALPS Advisors bought 18,608 Anavex Life Sciences shares in Q2 2026, an estimated $55.1K.
  • Anavex Life Sciences made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #1138 holding.
  • ALPS Advisors first reported a position in Anavex Life Sciences in Q4 2021 and has held it in 19 quarters since.
  • ALPS Advisors's Anavex Life Sciences position peaked at $1.52M in Q4 2021.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.